Oral mucosa lesions and oral symptoms in inflammatory Bowel disease patients;Lesões das mucosas orais e sintomatologia oral em doentes com doença inflamatória intestinal. Arq Gastroenterol

Arquivos de Gastroenterologia

Volumn 52, Issue 2, 2015, Pages 105-110

  Laranjeira, Nuno ^a   Fonseca, Jorge ^a,b   Meira, Tânia ^b   Freitas, João ^b   Valido, Sara ^a   Leitão, Jorge ^c  

^a INSTITUTO SUPERIOR DE CIÊNCIAS DA SAÚDE EGAS MONIZ   (Portugal)

^b HOSPITAL GARCIA DE ORTA   (Portugal)

^c Portuguese Catholic University Viseu   (Portugal)

Author keywords

Aphthous stomatitis; Infammatory bowel diseases; Mouth mucosa

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; MOUTH EXAMINATION; MOUTH HYGIENE; ORAL MUCOSAL DISEASE; SMOKING; ULCERATIVE COLITIS; VERY ELDERLY; CASE CONTROL STUDY; COMPLICATION; MIDDLE AGED; MOUTH DISEASES; RISK FACTOR; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH DISEASES; ORAL HYGIENE; RISK FACTORS; SMOKING; YOUNG ADULT;

EID: 84930515456     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/S0004-28032015000200006     Document Type: Article

References (26)

1. Ardizzone S, Puttini PS, Cassinotti a, Porro GB. Extraintestinal manifestations of infammatory bowel disease. Dig Liver Dis. 2008;40(Suppl 2):S253-9.
2. Asquith P, Thompson RA, Cooke WT. Oral manifestations of Crohn’s disease. Gut. 1975;16(4):249-54.
3. Blumberg RS, Saubermann LJ, Strober W. Animal models of mucosal infamma-tion and their relation to human infammatory bowel disease. Curr Opin Immunol. 1999;11(6):648-56.
4. Boisnic S. Cheilitis. Rev Prat. 2002;52(4):3704.
5. Brito F, de Barros FC, Zaltman C, Carvalho ATP, Carneiro AJDV, Fischer RG, et al. Prevalence of periodontitis and DMFT index in patients with Crohn’s disease and ulcerative colitis. J Clin Periodontol. 2008;35(6):555-60.
6. Daley TD, Armstrong JE. Oral manifestations of gastrointestinal diseases. Can J Gastroenterol. 2007;21(4):241-4.
7. Elahi M, Telkabadi M, Samadi V, Vakili H. Association of oral manifestations with ulcerative colitis. Gastroenterol Hepatol Bed Bench. 2012;5(3):155-60.
8. Fatahzadeh M. Infammatory bowel disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. Elsevier Inc.; 2009;108(5):e1-10.
9. Flemmig TF, Shanahan F, Miyasaki KT. Prevalence and severity of periodon-tal disease in patients with infammatory bowel disease. J Clin Periodontol. 1991;18(9):690-7.
10. Galbraith SS, Drolet B a, Kugathasan S, Paller AS, Esterly NB. Asymptomatic infammatory bowel disease presenting with mucocutaneous findings. Pediatrics. 2005;116(3):e439-44.
11. Gassull M, Gomollón F, Hinojosa J, Obrador A. Enfermedad Infamatoria Intestinal. 3rd ed. Madrid: Arán Ediciones; 2007.
12. Grössner-Schreiber B, Fetter T, Hedderich J, Kocher T, Schreiber S, Jepsen S. Prevalence of dental caries and periodontal disease in patients with infammatory bowel disease: a case-control study. J Clin Periodontol. 2006;33(7):478-84.
13. Habashneh R A, Khader YS, Alhumouz MK, Jadallah K, Ajlouni Y. The association between infammatory bowel disease and periodontitis among Jordanians: a case-control study. J Periodontal Res. 2012;47(3):293-8.
14. Harvey RF, Bradshaw JM. A simple index of Crohn’s-disease activity. Lancet. 1980;1(8167):514.
15. Katz J, Shenkman A, Stavropoulos F, Melzer E. Oral signs and symptoms in relation to disease activity and site of involvement in patients with infammatory bowel disease. Oral Dis. 2003;9(1):34-40.
16. Leão JC, Hodgson T, Scully C, Porter S. Review article: orofacial granulomatosis. Aliment Pharmacol Ther. 2004;20(10):1019-27.
17. Lourenço S V, Hussein TP, Bologna SB, Sipahi a M, Nico MMS. Oral manifestations of infammatory bowel disease: a review based on the observation of six cases. J Eur Acad Dermatol Venereol. 2010;24(2):204-7.
18. Neville B W, Damm DD, Allen CM, Bouquot JE. Patologia Oral e Maxilofacial. 2nd ed. Koogan G, editor. Rio de Janeiro; 2004.
19. Ojha J, Cohen DM, Islam NM, Stewart CM, Katz J, Bhattacharyya I. Gingival involvement in Crohn disease. J Am Dent Assoc. 2007;138(12):1574-81.
20. Pittock S, Drumm B, Fleming P, McDermott M, Imrie C, Flint S, et al. The oral cavity in Crohn’s disease. J Pediatr. 2001;138(5):767-71.
21. Rampton D. Infammatory Bowel Disease Clinical Diagnosis and Manegement. London: Martin Dunitz; 2000.
22. Satsangi J, Morecroft J, Shah NB, Nimmo E. Genetics of infammatory bowel disease: scientific and clinical implications. Best Pract Res Clin Gastroenterol. 2003;17(1):3-18.
23. Satsangi J, Silverberg MS, Vermeire S, Colombel J-F. The Montreal classification of infammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55(6):749-53.
24. Scheper HJ, Brand HS. Oral aspects of Crohn’s disease. Int Dent J. 2002;52(3):163-72.
25. Scully C, Cochran KM, Russell RI, Ferguson MM, Ghouri MA, Lee FD, et al. Crohn’s disease of the mouth: an indicator of intestinal involvement. Gut. 1982;23(3):198-201.
26. Sleisenger MH. Pathophysiology of the gastrointestinal tract. In: Smith LH, Thie SO, editors. Pathophysiology: the biologic principles of disease. Philadelphia: The W. B. Sauders Co.; 1981. p. 1506-689.